Spread of Dermatophytes Among Families
Demonstration of the Spread of Dermatophytes Through Casual Contact Among Family Household Members
1 other identifier
observational
50
1 country
1
Brief Summary
The objective is to demonstrate person-to-person spread of dermatophytes of the skin and nails among family members, as measured by fungal culture and DNA typing of the dermatophytes isolated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 3, 2005
CompletedFirst Posted
Study publicly available on registry
October 5, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedResults Posted
Study results publicly available
November 1, 2024
CompletedNovember 1, 2024
August 1, 2024
3.8 years
October 3, 2005
July 6, 2021
August 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dermatophyte Species Distribution
To identify dermatophytes isolates known to cause onychomycosis and/or tinea pedis by Polymerase Chain Reaction (PCR)
Baseline
Secondary Outcomes (3)
Dermatophyte Strain Types Among All Enrolled Households
Baseline
Number of Households With Dermatophyte Infection Spread
Baseline
Number of Participants Affected by the Association of Spread of Infection and History of Tinea Pedis or Onychomycosis
Baseline
Eligibility Criteria
Study Design-Households with at least 2 residents and 1 individual (index person \[IP\]) with tinea pedis and/or onychomycosis were identified by screening. Infection was confirmed clinically and mycologically (potassium hydroxide \[KOH\] and culture positive) in the IP; then other members within the same household were examined for tinea pedis and/or onychomycosis using the same criteria. All participants with confirmed fungal infections were referred to their primary care physicians for appropriate treatment.
You may not qualify if:
- use of antifungal agents, either oral or topical
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
A cross-sectional, not longitudinal, analysis; therefore, we were unable to determine the chronology of infection, the cause-and-effect relationship between specific strain types and infection, or the household member that was infected first.
Results Point of Contact
- Title
- Dr. Mahmoud Ghannoum
- Organization
- University Hospitals Cleveland Medical Center Center for Medical Mycology
Study Officials
- PRINCIPAL INVESTIGATOR
Mahmoud A Ghannoum, PhD
Center for Medical Mycology, University Hospitals Cleveland Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2005
First Posted
October 5, 2005
Study Start
March 1, 2005
Primary Completion
January 1, 2009
Study Completion
May 1, 2013
Last Updated
November 1, 2024
Results First Posted
November 1, 2024
Record last verified: 2024-08